Related references
Note: Only part of the references are listed.Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study
Sarah C. J. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Eradicating Bacterial Persisters with Combinations of Strongly and Weakly Metabolism-Dependent Antibiotics
Erica J. Zheng et al.
CELL CHEMICAL BIOLOGY (2020)
Effect of tolerance on the evolution of antibiotic resistance under drug combinations
Jiafeng Liu et al.
SCIENCE (2020)
A multiplexable assay for screening antibiotic lethality against drug-tolerant bacteria
Jonathan M. Stokes et al.
NATURE METHODS (2019)
Drug combinations: a strategy to extend the life of antibiotics in the 21 st century
Mike Tyers et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Prediction of ultra-high-order antibiotic combinations based on pairwise interactions
Itay Katzir et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Variation in Mutant Prevention Concentrations
Crystal Gianyecchio et al.
FRONTIERS IN MICROBIOLOGY (2019)
Definitions and guidelines for research on antibiotic persistence
Nathalie Q. Balaban et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Epistasis between antibiotic tolerance, persistence, and resistance mutations
Irit Levin-Reisman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Evaluation of TD test for analysis of persistence or tolerance in clinical isolates of Staphylococcus aureus
Hana Kotkova et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2019)
Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Payam Nahid et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Species-specific activity of antibacterial drug combinations
Ana Rita Brochado et al.
NATURE (2018)
Salmonella persisters undermine host immune defenses during antibiotic treatment
Daphne A. C. Stapels et al.
SCIENCE (2018)
Additivity of inhibitory effects in multidrug combinations
D. Russ et al.
NATURE MICROBIOLOGY (2018)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Persistent bacterial infections and persister cells
Robert A. Fisher et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Antibiotic tolerance facilitates the evolution of resistance
Irit Levin-Reisman et al.
SCIENCE (2017)
RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host
Erin S. Honsa et al.
MBIO (2017)
TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay
Orit Gefen et al.
SCIENTIFIC REPORTS (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Multidrug evolutionary strategies to reverse antibiotic resistance
Michael Baym et al.
SCIENCE (2016)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Prediction of resistance development against drug combinations by collateral responses to component drugs
Christian Munck et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Relationship of In Vitro Synergy and Treatment Outcome with Daptomycin plus Rifampin in Patients with Invasive Methicillin-Resistant Staphylococcus aureus Infections
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Pharmaco -, Population and Evolutionary Dynamics of Multi-drug Therapy: Experiments with S. aureus and E. coli and Computer Simulations
Peter Ankomah et al.
PLOS PATHOGENS (2013)
Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum
Peter Ankomah et al.
PLOS PATHOGENS (2012)
Managing drug resistance in cancer: lessons from HIV therapy
Christoph Bock et al.
NATURE REVIEWS CANCER (2012)
Population Dynamics of Antibiotic Treatment: a Mathematical Model and Hypotheses for Time-Kill and Continuous-Culture Experiments
Bruce R. Levin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection
O. Cirioni et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2010)
Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis
Lawrence R. Mulcahy et al.
JOURNAL OF BACTERIOLOGY (2010)
Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
Kerry L. LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antibiotic interactions that select against resistance
Remy Chait et al.
NATURE (2007)
Multicomponent therapeutics for networked systems
CT Keith et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus
JA Silverman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antibiotic synergy and antagonism
JF Acar
MEDICAL CLINICS OF NORTH AMERICA (2000)